← All trials
NCT03113786
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 2, 2011
- Primary completion
- Dec 1, 2017
- Completion date
- Dec 1, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Amniox Medical, Inc.Lead sponsor
- Tissue Tech Inc.Study chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.